
AI and Health: Discussing The New Perimeter of Decision-Making in Rome
Aindo hosted a strategic dialogue between institutions, industry, and research to define the future of data governance and regulatory access.
Aindo hosted a strategic dialogue between institutions, industry, and research to define the future of data governance and regulatory access.
On April 15, 2026, the event “AI and Health: The New Perimeter of Decision-Making” took place in Rome. Organized by Aindo, the summit provided a unique occasion for experts from institutions, the private sector, and academia to confront two fundamental dimensions defining the future of digital health.
The first dimension is regulatory decision-making. As AI and synthetic data increasingly enter evidence generation workflows, the priority remains ensuring high quality, methodological validity, and their integration into HTA (Health Technology Assessment) and market access frameworks.
The second dimension is governance. While health data is abundant, it is often fragmented and siloed. Unlocking its full value requires precise, standardized conditions regarding access and infrastructure.
Key points that emerged with great force from the discussion included:
This is a change already in motion. Bridging the gap between technological potential and practical application requires a collective awareness and, above all, the implementation of concrete, coordinated actions.

Aindo hosted a strategic dialogue between institutions, industry, and research to define the future of data governance and regulatory access.

Aindo and IQVIA Italy join forces to scale synthetic data adoption in the Italian healthcare ecosystem.

Under the patronage of Regione Lombardia, Aindo gathered leading IRCCS directors, pharma leaders, and institutions to shape the future of AI in healthcare.